MedPath

Factors Associating Reluctance to Initiate or Continue Oral Antihyperglycemic Agent (OAHA) Treatments in Type 2 Diabetes Mellitus Patients in Japan: Observational, Cross-sectional, Patient-Reported and Web-Based Survey

Not Applicable
Conditions
Type 2 diabetes mellitus
Registration Number
JPRN-UMIN000026086
Lead Sponsor
MSD K.K.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
625
Inclusion Criteria

Not provided

Exclusion Criteria

Diagnosed with Type 1 Diabetes Mellitus Pregnant Drug-induced T2DM (Above listed 1 & 2) told by physician already being well-controlled on their glycemic levels and currently no need to engage in D&E therapy

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath